Project Details
Description
A Multicenter, Open-Label Phase 1b/2 Study of Ibrutinib for Steroid Dependent or Refractory Chronic Graft Versus Host Disease
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/14 → 8/30/19 |
Funding
- PHARMACYCLICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.